We are live on
!
Find out more
AIP
ARS Investment Partners Portfolio holdings
AUM
$2.29B
1-Year Est. Return
113.95%
This Fund
S&P 500
This Quarter
Est. Return
+21.56%
1 Year Est. Return
+113.95%
3 Year Est. Return
+260.1%
5 Year Est. Return
+332.48%
10 Year Est. Return
+1,634.5%
AUM
$552M
AUM Growth
+$79.9M
(+17%)
Cap. Flow
-$6.06M
Cap. Flow
% of AUM
-1.1%
Top 10 Holdings %
Top 10 Hldgs %
41.07%
Holding
120
New
8
Increased
25
Reduced
72
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Skyworks Solutions
SWKS
|
+$11.4M |
| 2 |
CELG
Celgene Corp
CELG
|
+$10.9M |
| 3 |
Lam Research
LRCX
|
+$7.84M |
| 4 |
Martin Marietta Materials
MLM
|
+$5.21M |
| 5 |
EBIX
Ebix Inc
EBIX
|
+$3.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$7.81M |
| 2 |
American Electric Power
AEP
|
+$6.25M |
| 3 |
Newell Brands
NWL
|
+$5.69M |
| 4 |
Universal Display
OLED
|
+$5.59M |
| 5 |
Zscaler
ZS
|
+$4.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.67% |
| 2 | Communication Services | 14.88% |
| 3 | Healthcare | 11.35% |
| 4 | Energy | 7.38% |
| 5 | Financials | 6.15% |
Similar funds
AFM
LCM
RA
MA
ST
GCP
LCM
MAP
ARS Investment Partners's Q1 2019 Portfolio in Review
As of Q1 2019, ARS Investment Partners held 120 positions worth $552M, up 17% from $473M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
ARS Investment Partners's Q1 2019 filing shows 8 new, 25 increased, 72 reduced and 5 closed positions. Its largest new stake was Skyworks Solutions: 147,652 shares worth $12.2M. The largest sale was Bristol-Myers Squibb, an estimated $7.81M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 24% a quarter earlier, followed by Communication Services and Healthcare.
- ARS Investment Partners's largest Q1 2019 buy was Skyworks Solutions: 147,652 shares worth $12.2M.
- ARS Investment Partners added most to Lam Research in Q1 2019, an estimated $7.84M increase.
- ARS Investment Partners's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $7.81M.
- ARS Investment Partners fully exited Kellanova in Q1 2019, selling an estimated $2.9M.
- ARS Investment Partners's ten largest holdings make up 41% of its $552M portfolio in Q1 2019.
- ARS Investment Partners opened 8 new positions and closed 5 in Q1 2019.
- ARS Investment Partners's portfolio value rose 17% quarter-over-quarter to $552M.
Based on ARS Investment Partners's 13F filing for Q1 2019, filed 9 May 2019.